R&D Archives - Pharmaphorum

Lilly focuses on tau with AC Immune Alzheimer’s R&D tie-up

https://pharmaphorum.com/news/lilly-focuses-on-tau-with-ac-immune-alzheimers-rd-tie-up/

Astellas gains three cancer drugs with $405m Potenza buy

https://pharmaphorum.com/news/astellas-gains-three-cancer-drugs-with-405m-potenza-buy/

Neurocrine slumps as Tourette’s drug fails clinical trial

https://pharmaphorum.com/news/neurocrine-slumps-as-tourettes-drug-fails-clinical-trial/

Axovant axes neuroscience drug, focuses on gene therapies

https://pharmaphorum.com/news/axovant-axes-neuroscience-drug-focuses-on-gene-therapies/

Certain brain tumours could respond to immunotherapy

https://pharmaphorum.com/news/certain-brain-tumours-could-respond-to-immunotherapy/

Merck KGaA links with AI firm to iron out side-effects during R&D

https://pharmaphorum.com/news/merck-kgaa-links-with-ai-firm-to-iron-out-side-effects-during-rd/

Digital health round-up: Market worth $379bn and still growing

https://pharmaphorum.com/views-and-analysis/digital-health-round-up-market-worth-379bn-and-still-growing/

Awards for AI-based drug R&D continue for second year

https://pharmaphorum.com/news/awards-for-ai-based-drug-rd-continue-for-second-year/

UCB, Roche, and IQVIA take lead in UK life sciences investment

https://pharmaphorum.com/news/ucb-roche-and-iqvia-take-lead-in-uk-life-sciences-investment/

Search